1. Therapeutic targeting of hypoxia inducible factor in acute respiratory distress syndrome.
- Author
-
Tran, Thu T., Eltzschig, Holger K., and Yuan, Xiaoyi
- Subjects
- *
ADULT respiratory distress syndrome , *TARGETED drug delivery , *HYPOXEMIA , *BRAIN injuries , *HUMAN physiology , *MEDICAL care - Abstract
Acute respiratory distress syndrome (ARDS) is characterized by bilateral chest infiltration and acute hypoxic respiratory failure. ARDS carries significant morbidity and mortality despite advancements in medical management, calling for the development of novel therapeutic targets. Hypoxia‐inducible factor (HIF) is a heterodimeric protein involved in various essential pathways, including metabolic reprogramming, immune modulation, angiogenesis and cell cycle regulation. HIF is routinely degraded in homeostasis conditions via the prolyl hydroxylase domain/von Hippel–Lindau protein pathway. However, HIF is stabilized in ARDS via various mechanisms (oxygen‐dependent and independent) as an endogenous protective pathway and plays multifaceted roles in different cell populations. This review focuses on the functional role of HIF and its target genes during ARDS, as well as how HIF has evolved as a therapeutic target in current medical management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF